S&P 500

5.267,84

-0,74%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Avexis, Inc. (delisted) (AVXS)
Avexis, Inc. (delisted) (AVXS) Notícias

AVXS

AVEXIS, INC. (AVXS)

Avexis, Inc. (delisted)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:AVXS

1 2 3 4 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
11/06/2018	11:01	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:AVXS	Avexis, Inc. (delisted)
06/06/2018	12:04	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:AVXS	Avexis, Inc. (delisted)
04/06/2018	18:25	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:AVXS	Avexis, Inc. (delisted)
23/05/2018	07:02	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:AVXS	Avexis, Inc. (delisted)
17/05/2018	12:49	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:AVXS	Avexis, Inc. (delisted)
15/05/2018	13:51	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:AVXS	Avexis, Inc. (delisted)
15/05/2018	13:44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AVXS	Avexis, Inc. (delisted)
15/05/2018	13:34	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:AVXS	Avexis, Inc. (delisted)
15/05/2018	13:32	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:AVXS	Avexis, Inc. (delisted)
15/05/2018	13:21	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AVXS	Avexis, Inc. (delisted)
15/05/2018	10:04	Edgar (US Regulatory)	(25-NSE)	NASDAQ:AVXS	Avexis, Inc. (delisted)
15/05/2018	08:28	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:AVXS	Avexis, Inc. (delisted)
15/05/2018	08:04	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:AVXS	Avexis, Inc. (delisted)
04/05/2018	18:10	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:AVXS	Avexis, Inc. (delisted)
03/05/2018	17:01	GlobeNewswire Inc.	AveXis Reports First Quarter 2018 Financial and Operating Results	NASDAQ:AVXS	Avexis, Inc. (delisted)
02/05/2018	10:27	GlobeNewswire Inc.	AveXis Provides Update on Proposed Acquisition by Novartis AG	NASDAQ:AVXS	Avexis, Inc. (delisted)
30/04/2018	18:26	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:AVXS	Avexis, Inc. (delisted)
25/04/2018	09:00	GlobeNewswire Inc.	AveXis Announces First Patient Dosed in Phase 3 Trial of AVXS-101 in Pre-Symptomatic SMA Types 1, 2 and 3	NASDAQ:AVXS	Avexis, Inc. (delisted)
24/04/2018	17:01	GlobeNewswire Inc.	AveXis Presents Initial Data from Pivotal U.S. Trial for SMA Type 1 and 24-Month Follow-Up Data from Phase 1 Trial of AVXS-10...	NASDAQ:AVXS	Avexis, Inc. (delisted)
20/04/2018	12:51	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:AVXS	Avexis, Inc. (delisted)
19/04/2018	09:00	GlobeNewswire Inc.	AveXis to Present AVXS-101 Data at the Annual Meeting of the American Academy of Neurology	NASDAQ:AVXS	Avexis, Inc. (delisted)
17/04/2018	17:29	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:AVXS	Avexis, Inc. (delisted)
17/04/2018	17:28	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:AVXS	Avexis, Inc. (delisted)
11/04/2018	18:41	PR Newswire (US)	WEISSLAW LLP Investigates AveXis Inc. Acquisition	NASDAQ:AVXS	Avexis, Inc. (delisted)
10/04/2018	17:49	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:AVXS	Avexis, Inc. (delisted)
10/04/2018	04:02	Dow Jones News	Novartis Deal to Help Drug Pipeline -- WSJ	NASDAQ:AVXS	Avexis, Inc. (delisted)
10/04/2018	04:02	Dow Jones News	What's News: Business & Finance -- WSJ	NASDAQ:AVXS	Avexis, Inc. (delisted)
09/04/2018	18:28	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:AVXS	Avexis, Inc. (delisted)
09/04/2018	13:59	Dow Jones News	Gene-Therapy Stocks Get Boost as Analysts Speculate Novartis' Next Target -- Market Mover	NASDAQ:AVXS	Avexis, Inc. (delisted)
09/04/2018	13:00	Dow Jones News	Novartis Buying AveXis for $8.7 Billion -- Deal Digest	NASDAQ:AVXS	Avexis, Inc. (delisted)